141699-56-1 Usage
Description
3-METHANESULFONYLOXYMETHYL-PYRROLIDINE-1-CARBOXYLIC ACID TERT BUTYL ESTER is a tert-butyl ester derivative of pyrrolidine-1-carboxylic acid, featuring a methanesulfonyloxymethyl group attached to the pyrrolidine ring. This chemical compound is utilized as a reagent in organic synthesis and pharmaceutical research, serving as a protecting group or a precursor for synthesizing other compounds. Its unique structure and properties render it a valuable tool for chemists and researchers in organic chemistry and drug development.
Uses
Used in Organic Synthesis:
3-METHANESULFONYLOXYMETHYL-PYRROLIDINE-1-CARBOXYLIC ACID TERT BUTYL ESTER is used as a reagent for facilitating various chemical reactions in organic synthesis. Its presence allows for the protection of certain functional groups during the synthesis process, ensuring the successful formation of desired products.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 3-METHANESULFONYLOXYMETHYL-PYRROLIDINE-1-CARBOXYLIC ACID TERT BUTYL ESTER is used as a precursor for the synthesis of biologically active molecules. Its ability to mediate chemical reactions contributes to the development of new drugs and therapeutic agents.
Used in Protecting Group Chemistry:
3-METHANESULFONYLOXYMETHYL-PYRROLIDINE-1-CARBOXYLIC ACID TERT BUTYL ESTER is used as a protecting group in organic synthesis, particularly in the synthesis of complex organic molecules. It helps to prevent unwanted side reactions by temporarily blocking reactive functional groups, allowing for selective reactions to occur.
Used in Drug Development:
3-METHANESULFONYLOXYMETHYL-PYRROLIDINE-1-CARBOXYLIC ACID TERT BUTYL ESTER is utilized in drug development for its potential to contribute to the creation of new pharmaceutical compounds. Its role in the synthesis of biologically active molecules makes it a valuable asset in the discovery and development of novel therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 141699-56-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,1,6,9 and 9 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 141699-56:
(8*1)+(7*4)+(6*1)+(5*6)+(4*9)+(3*9)+(2*5)+(1*6)=151
151 % 10 = 1
So 141699-56-1 is a valid CAS Registry Number.
InChI:InChI=1/C11H21NO5S/c1-11(2,3)17-10(13)12-6-5-9(7-12)8-16-18(4,14)15/h9H,5-8H2,1-4H3
141699-56-1Relevant articles and documents
ISOINDOLINONE COMPOUNDS
-
Page/Page column 283-284, (2021/04/17)
Disclosed herein is a compound or pharmaceutically acceptable salts or stereoisomers thereof of of formula I wherein X1 is linear or branched C1-6 alkyl, C3-6 cycloalkyl, -C1-6 alkyl C3-6 cycloalkyl, C6-10 aryl, 5-10 membered heteroaryl, C1-6 alkyl C6-10 aryl, C1-6 alkyl 5-10 membered heteroaryl, wherein X1 is unsubstituted or substituted with one or more of halogen, linear or branched C1-6 alkyl, linear or branched C1-6 heteroalkyl, CF3, CHF2, -O-CHF2, -O-(CH2)2-OMe, OCF3, C1-6 alkylamino, -CN, -N(H)C(O)-C1- 6alkyl, -OC(O)-C1-6alkyl, -OC(O)-C1-4alkylamino, -C(O)O-C1-6alkyl, -COOH, - CHO, -C1-6alkylC(O)OH, -C1-6alkylC(O)O-C1-6alkyl, NH2, C1-6 alkoxy or C1-6 alkylhydroxy; X2 is hydrogen, C6-10 aryl, 5-10 membered heteroaryl, -O-(5-10 membered heteroaryl), 4-8 membered heterocycloalkyl, C1-4 alkyl 4-8 membered heterocycloalkyl, -O-(4-8 membered heterocycloalkyl), -O-C1-4 alkyl-(4-8 membered heterocycloalkyl), -OC(O)-C1-4alkyl-4-8 membered heterocycloalkyl or C6 aryloxy, wherein X2 is unsubstituted or substituted with one or more of linear or branched C1-6 alkyl, NH2, NMe2 or 5-6 membered heterocycloalkyl; n is 0, 1 or 2.
SSAO INHIBITORS AND USE THEREOF
-
Paragraph 00672, (2021/05/07)
Provided are a compound of formula (I') or (I), a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which modulates the activity of SSAO, a pharmaceutical composition comprising a compound of formula (I') or (I), and a method of treating or preventing a disease in which SSAO plays a role.
2-(BICYCLO-HETEROARYL)-ISONICOTINIC DERIVATIVES AS HISTONE DEMETHYLASE INHIBITORS
-
Paragraph 80, (2018/09/12)
The invention relates to compounds of Formula (I) as described herein, useful as histone demethylase inhibitors. The invention also relates to pharmaceutical compositions comprising these compounds and to their use in therapy, including e.g., in the treatment of cancer.
